view페이지

Announcement: An annual general meeting of stockholders

Feb 06, 2014PRESS RELEASESHit 1595

Notice is given to the shareholders of MedPacto, Inc. to the Annual General Meeting to be held in accordance with Korean commercial sale of goods Act 363

 

Date : February 25 2014, 7:00 PM

Location :
Samjung Hotel, #150 Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea


February 6 2014

 

Attachments 20140814 임시주주총회 소집 공고.docx
Next MedPacto, Inc. and OncoVenture have submitted IND application to US FDA for Medpacto's oral ALK5 inhibitor, TEW-7197.
Previous National OncoVenture (NOV) announces the support of development of MedPacto’s leading anticancer drug candidate, TEW-7197